Literature DB >> 22689803

Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature.

Mariko D DeWire1, Chris Beltran, Frederick A Boop, Kathleen J Helton, David W Ellison, Peter J McKinnon, Amar Gajjar, Atmaram S Pai Panandiker.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22689803      PMCID： PMC4881371          DOI： 10.1200/JCO.2011.40.1430

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  23 in total

1.  Ataxia-telangiectasia complicated by craniopharyngioma--a new observation.

Authors:  Amira T Masri; Faris G Bakri; Azmy M Al-Hadidy; Awni F Musharbash; Maisa Al-Hussaini
Journal:  Pediatr Neurol       Date:  2006-10       Impact factor: 3.372

2.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

3.  Multiple neoplasms in an adolescent child associated with IGA deficiency.

Authors:  A B Hamoudi; I Ertel; W A Newton; C B Reiner; H W Clatworthy
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

4.  Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay.

Authors:  Y K Huo; Z Wang; J H Hong; L Chessa; W H McBride; S L Perlman; R A Gatti
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

5.  Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

Authors:  A Niemierko; M Goitein
Journal:  Radiother Oncol       Date:  1993-11       Impact factor: 6.280

6.  New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases.

Authors:  Pascale Varlet; Deepa Soni; Catherine Miquel; François-Xavier Roux; Jean-François Meder; Herve Chneiweiss; Catherine Daumas-Duport
Journal:  Neurosurgery       Date:  2004-12       Impact factor: 4.654

7.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

8.  Three consecutive primary malignancies in one patient during childhood.

Authors:  J J Groot-Loonen; R Slater; J Taminiau; P A Voûte
Journal:  Pediatr Hematol Oncol       Date:  1988       Impact factor: 1.969

9.  Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

Authors:  Ninette Amariglio; Abraham Hirshberg; Bernd W Scheithauer; Yoram Cohen; Ron Loewenthal; Luba Trakhtenbrot; Nurit Paz; Maya Koren-Michowitz; Dalia Waldman; Leonor Leider-Trejo; Amos Toren; Shlomi Constantini; Gideon Rechavi
Journal:  PLoS Med       Date:  2009-02-17       Impact factor: 11.069

10.  Early diagnosis of ataxia-telangiectasia using radiosensitivity testing.

Authors:  Xia Sun; Sara G Becker-Catania; Helen H Chun; Mee Jeong Hwang; Yong Huo; Zhijun Wang; Midori Mitui; Ozden Sanal; Luciana Chessa; Barbara Crandall; Richard A Gatti
Journal:  J Pediatr       Date:  2002-06       Impact factor: 4.406
View more
  6 in total

Review 1.  Primary immunodeficiencies and their associated risk of malignancies in children: an overview.

Authors:  Samuele Renzi; Karin Petra Sabine Langenberg-Ververgaert; Nicolas Waespe; Salah Ali; Jack Bartram; Orli Michaeli; Julia Upton; Michaela Cada
Journal:  Eur J Pediatr       Date:  2020-03-11       Impact factor: 3.183

2.  Identifying the Radioresponsive Genome for Genomics-Guided Radiotherapy.

Authors:  Catharine M L West
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

3.  Transcriptional Dynamics of DNA Damage Responsive Genes in Circulating Leukocytes during Radiotherapy.

Authors:  Lourdes Cruz-Garcia; Farah Nasser; Grainne O'Brien; Jakub Grepl; Volodymyr Vinnikov; Viktor Starenkiy; Sergiy Artiukh; Svetlana Gramatiuk; Christophe Badie
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

Review 4.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

5.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

6.  Malignant Glioma with Neuronal Marker Expression : A Clinicopathological Study of 18 Cases.

Authors:  Hong Rye Kim; Jae Jun Lee; Jung-Il Lee; Do Hyun Nam; Yeon-Lim Suh; Ho Jun Seol
Journal:  J Korean Neurosurg Soc       Date:  2016-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.